U.S. Physical Therapy’s (USPH) “Outperform” Rating Reaffirmed at Barrington Research

U.S. Physical Therapy (NYSE:USPH)‘s stock had its “outperform” rating reaffirmed by research analysts at Barrington Research in a research report issued to clients and investors on Thursday,Benzinga reports. They presently have a $108.00 target price on the stock. Barrington Research’s price target indicates a potential upside of 10.40% from the company’s previous close.

Several other equities research analysts also recently weighed in on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Bank of America restated a “neutral” rating and set a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.

U.S. Physical Therapy Stock Performance

USPH stock opened at $97.83 on Thursday. U.S. Physical Therapy has a one year low of $76.18 and a one year high of $113.63. The firm has a market cap of $1.48 billion, a price-to-earnings ratio of 104.32, a PEG ratio of 4.10 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a 50-day simple moving average of $84.95 and a two-hundred day simple moving average of $90.89.

Insider Buying and Selling at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the transaction, the chief operating officer now owns 7,106 shares of the company’s stock, valued at $684,236.74. This trade represents a 19.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the transaction, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. This trade represents a 11.83 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 6,896 shares of company stock worth $656,940. 1.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of the stock. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $28,000. Innealta Capital LLC acquired a new position in shares of U.S. Physical Therapy in the second quarter worth about $30,000. Quest Partners LLC boosted its stake in shares of U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares in the last quarter. Quarry LP grew its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company’s stock valued at $48,000 after acquiring an additional 478 shares during the period. Finally, Ridgewood Investments LLC purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at about $51,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.